Johnson & Johnson’s Rybrevant shows 45% response rate in HNSCC
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
New test expands access to early Alzheimer’s assessment, streamlining diagnostic pathways and improving referral efficiency
The new plant will manufacture high-quality Type I borosilicate glass tubing
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
The anatomage table is one of the most advanced 3D real-tissue–based anatomy visualization systems in the world
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
The company plans to use the funds raised from the net proceeds to repay or prepay certain loans
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
Subscribe To Our Newsletter & Stay Updated